Insights

Global Market Leadership Novartis Consumer Health is a dominant player in over thirty countries and holds the top position worldwide for over-the-counter medicines, indicating strong brand recognition and extensive international reach that offers numerous opportunities for expanding distribution channels and introducing new products.

Strategic Expansion Recent significant investments in manufacturing facilities across North Carolina and Japan demonstrate the company's commitment to scaling production capacity, which can facilitate faster product supply and create opportunities for partnerships in logistics, packaging, and supply chain services.

Innovative Technology Use Utilizing advanced tech stacks like Apache Spark, SonarQube, and Autodesk Fusion 360 suggests a focus on digital transformation and efficient manufacturing processes, opening avenues for sales in software solutions, automation, and data analytics tools.

Financial Strength With revenues between 500 million and 1 billion dollars and a funding pool of 2.4 billion dollars, Novartis has substantial financial resources to invest in new product lines, marketing initiatives, and strategic partnerships to accelerate growth and market penetration.

Market Focus & Opportunity As the market leader in OTC medicines with key brands like Sensodyne and Voltaren, there are opportunities to upsell and cross-sell to existing customers, explore new product formulations, and expand into emerging markets with targeted marketing and distribution strategies.

Similar companies to Novartis Consumer Health

Novartis Consumer Health Tech Stack

Novartis Consumer Health uses 8 technology products and services including Crazy Egg, Apache Spark, Autodesk Fusion 360, and more. Explore Novartis Consumer Health's tech stack below.

  • Crazy Egg
    Analytics
  • Apache Spark
    Big Data Processing
  • Autodesk Fusion 360
    Cad & Graphics
  • Sprinklr
    Customer Experience Management
  • SonarQube
    Development
  • Web Vitals
    Javascript Libraries
  • Cisco Prime Infrastructure
    Network Management
  • Windows Server 2012
    Operating Systems

Media & News

Novartis Consumer Health's Email Address Formats

Novartis Consumer Health uses at least 1 format(s):
Novartis Consumer Health Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
89%
F.Last@novartis.comJ.Doe@novartis.com
5%
FiLast@novartis.comJoDoe@novartis.com
3%
FLast@novartis.comJDoe@novartis.com
3%

Frequently Asked Questions

What is Novartis Consumer Health's official website and social media links?

Minus sign iconPlus sign icon
Novartis Consumer Health's official website is novartis.com and has social profiles on LinkedIn.

What is Novartis Consumer Health's NAICS code?

Minus sign iconPlus sign icon
Novartis Consumer Health's NAICS code is 31-33 - Manufacturing.

How many employees does Novartis Consumer Health have currently?

Minus sign iconPlus sign icon
As of December 2025, Novartis Consumer Health has approximately 5K employees across 6 continents, including North AmericaEuropeAsia. Key team members include CFO: B. S.Cro Coordinator: M. L.Cfo, Vp Finance North America: T. H.. Explore Novartis Consumer Health's employee directory with LeadIQ.

What industry does Novartis Consumer Health belong to?

Minus sign iconPlus sign icon
Novartis Consumer Health operates in the Manufacturing industry.

What technology does Novartis Consumer Health use?

Minus sign iconPlus sign icon
Novartis Consumer Health's tech stack includes Crazy EggApache SparkAutodesk Fusion 360SprinklrSonarQubeWeb VitalsCisco Prime InfrastructureWindows Server 2012.

What is Novartis Consumer Health's email format?

Minus sign iconPlus sign icon
Novartis Consumer Health's email format typically follows the pattern of First.Last@novartis.com. Find more Novartis Consumer Health email formats with LeadIQ.

How much funding has Novartis Consumer Health raised to date?

Minus sign iconPlus sign icon
As of December 2025, Novartis Consumer Health has raised $2.4B in funding. The last funding round occurred on Sep 16, 2020 for $2.1B.

Novartis Consumer Health

ManufacturingNew Jersey, United States1001-5000 Employees

Novartis and GSK have combined our Consumer Healthcare businesses to create a new joint venture Consumer Healthcare company. This new business is now a market leader in more than 30 countries as well as being the number one company worldwide for over-the-counter medicines. Some of our key brands now include: Sensodyne, Voltaren, Theraflu, Panadol, Otrivin, Horlicks, Zovirax & Abreva.

Section iconCompany Overview

NAICS Code
31-33 - Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $2.4B

    Novartis Consumer Health has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $500M$1B

    Novartis Consumer Health's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $2.4B

    Novartis Consumer Health has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $500M$1B

    Novartis Consumer Health's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.